<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00857402</url>
  </required_header>
  <id_info>
    <org_study_id>ArgII</org_study_id>
    <secondary_id>HLF_20060246</secondary_id>
    <nct_id>NCT00857402</nct_id>
  </id_info>
  <brief_title>Arginine as an Adjuvant Treatment Against Tuberculosis</brief_title>
  <official_title>Arginine Rich Food Supplementation as an Adjuvant Treatment Against Tuberculosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Gondar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kalmar County Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Linkoeping University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate if adjuvant treatment with arginine (the
      substrate for nitric oxide production) rich food supplements could improve clinical outcome
      in patients with smear positive tuberculosis by affecting nitric oxide production.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tuberculosis (TB) is disease of increased global public health importance. Because of
      emerging multi drug resistance and the long treatment duration there is a need to optimize
      the current chemotherapy. Host immunity is important in determining the susceptibility and
      outcome of disease as could be exemplified by co infection with HIV which dramatically
      increases the risk to develop TB.

      Previous results from our group and others show that nitric oxide produced by activated
      macrophages from arginine might be important to control the disease. However, the relative
      importance of nitric oxide in human TB has been debated. In a previous study in Gondar,
      Ethiopia, we observed an effect of adjuvant treatment with arginine capsules on sputum smear
      conversion and reduction of cough. In this study we wanted to test the hypothesis based on
      previous observations that an arginine rich food supplementation might enhance clinical
      improvement in patients with smear positive tuberculosis and if this effect could be due to
      increased nitric oxide production.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2004</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Final outcome according to WHO</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Chest X-ray pattern from baseline to 2 months</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of exhaled and urinary nitric oxide</measure>
    <time_frame>First week, week 2, week 8, and month 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight gain from baseline until 2 months</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedimentation rate</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sputum smear conversion</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of cough from baseline to 2 months</measure>
    <time_frame>1 and 2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Tuberculosis</condition>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Peanuts</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Daboqolo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Peanuts</intervention_name>
    <description>30g of peanuts daily for 4 weeks (directly observed). This dose of peanuts is equivalent to 1 gram of arginine.</description>
    <arm_group_label>Peanuts</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Daboqolo</intervention_name>
    <description>30g of Daboqolo per os daily for 4 weeks (given supervised). 30g of Daboqolo is equivalent to 0.1 g of arginine.</description>
    <arm_group_label>Daboqolo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed and written consent to take part in the study

          -  Previously untreated and newly diagnosed smear positive Tb patients according to the
             WHO definitions

        Exclusion Criteria:

          -  Hospitalization

          -  Pregnancy

          -  Known allergy against peanuts

          -  Chronic or acute disease other than tuberculosis/HIV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Schön, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Linkoeping University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sven Britton, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tommy Sundqvist, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Linkoeping University, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gondar University, DOTS-center</name>
      <address>
        <city>Gondar, Region 3, Ethiopia</city>
        <state>Gondar</state>
        <zip>P.o. box 106</zip>
        <country>Ethiopia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ethiopia</country>
  </location_countries>
  <reference>
    <citation>Schön T, Wolday D, Elias D, Melese E, Moges F, Tessema T, Stendahl O, Sundqvist T, Britton S. Kinetics of sedimentation rate, viral load and TNF-alpha in relation to HIV co-infection in tuberculosis. Trans R Soc Trop Med Hyg. 2006 May;100(5):483-8. Epub 2005 Oct 20.</citation>
    <PMID>16242741</PMID>
  </reference>
  <reference>
    <citation>Schön T, Elias D, Moges F, Melese E, Tessema T, Stendahl O, Britton S, Sundqvist T. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. Eur Respir J. 2003 Mar;21(3):483-8.</citation>
    <PMID>12662006</PMID>
  </reference>
  <reference>
    <citation>Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J. 1998 Apr;11(4):809-15.</citation>
    <PMID>9623681</PMID>
  </reference>
  <results_reference>
    <citation>Idh J, Westman A, Elias D, Moges F, Getachew A, Gelaw A, Sundqvist T, Forslund T, Alemu A, Ayele B, Diro E, Melese E, Wondmikun Y, Britton S, Stendahl O, Schön T. Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection. BMC Infect Dis. 2008 Oct 24;8:146. doi: 10.1186/1471-2334-8-146.</citation>
    <PMID>18950489</PMID>
  </results_reference>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2009</study_first_submitted>
  <study_first_submitted_qc>March 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2009</study_first_posted>
  <last_update_submitted>March 5, 2009</last_update_submitted>
  <last_update_submitted_qc>March 5, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>Thomas Schön</name_title>
    <organization>Linkoeping University</organization>
  </responsible_party>
  <keyword>Arginine</keyword>
  <keyword>Nitric oxide</keyword>
  <keyword>Peanuts</keyword>
  <keyword>Sedimentation rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

